Collegium Pharmaceutical Other Long Term Assets (Quarterly) Analysis

Collegium Pharmaceutical, Inc. (COLL)

46.80 -0.90 (-1.89%) USD | NASDAQ | Jan 21, 10:11

View Other Long Term Assets (Quarterly) for COLL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Catalyst Pharmaceuticals, Inc.	--
Intuitive Surgical, Inc.	Upgrade
Hims & Hers Health, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Corcept Therapeutics, Inc.	Upgrade